Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/209885
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSabaté, Manel-
dc.date.accessioned2024-04-15T13:49:26Z-
dc.date.available2024-04-15T13:49:26Z-
dc.date.issued2023-04-19-
dc.identifier.issn2604-7306-
dc.identifier.urihttp://hdl.handle.net/2445/209885-
dc.description.abstractWhat is the evidence available on the use of drug-coated balloons (DCB) in the de novo lesion setting?-
dc.format.extent2 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherPublicaciones Permanyer-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.24875/RECICE.M22000347-
dc.relation.ispartofREC: Interventional Cardiology, 2023, vol. 5, num.1, p. 62-63-
dc.relation.urihttps://doi.org/10.24875/RECICE.M22000347-
dc.rightscc-by-nc-nd (c) Sociedad Española de Cardiología, 2023-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationCardiologia-
dc.subject.classificationMalalties coronàries-
dc.subject.classificationFarmacologia-
dc.subject.otherCardiology-
dc.subject.otherCoronary diseases-
dc.subject.otherPharmacology-
dc.titleDebate. Drug-coated balloons for de novo coronary artery lesions. Still not enough evidence, and the new drug-eluting stents are still better-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec741046-
dc.date.updated2024-04-15T13:49:31Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9374927-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
837670.pdf99.9 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons